Deerfield Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,062
| Closed | -$488K | – | 600 |
|
|
2024
Q2 | $488K | Buy |
+17,062
| New | +$488K | 0.01% | 265 |
|
|
2023
Q1 | – | Sell |
-292,000
| Closed | -$11.3M | – | 110 |
|
|
2022
Q4 | $11.3M | Hold |
292,000
| – | – | 0.23% | 70 |
|
|
2022
Q3 | $15.5M | Hold |
292,000
| – | – | 0.31% | 71 |
|
|
2022
Q2 | $17M | Buy |
+292,000
| New | +$17M | 0.35% | 65 |
|
|
2022
Q1 | – | Sell |
-596,338
| Closed | -$35.9M | – | 126 |
|
|
2021
Q4 | $35.9M | Sell |
596,338
-370,898
| -38% | -$22.3M | 0.75% | 40 |
|
|
2021
Q3 | $54.2M | Sell |
967,236
-179,764
| -16% | -$10.1M | 1.06% | 28 |
|
|
2021
Q2 | $69.6M | Sell |
1,147,000
-17,973
| -2% | -$1.09M | 1.24% | 20 |
|
|
2021
Q1 | $81.7M | Buy |
1,164,973
+115,326
| +11% | +$8.08M | 1.72% | 14 |
|
|
2020
Q4 | $62.8M | Sell |
1,049,647
-148,178
| -12% | -$8.87M | 1.24% | 20 |
|
|
2020
Q3 | $72M | Sell |
1,197,825
-465,175
| -28% | -$28M | 1.75% | 15 |
|
|
2020
Q2 | $87.3M | Buy |
1,663,000
+35,479
| +2% | +$1.86M | 2.54% | 9 |
|
|
2020
Q1 | $54.6M | Buy |
+1,627,521
| New | +$54.6M | 1.73% | 16 |
|
|
2016
Q3 | – | Sell |
-50,000
| Closed | -$1.69M | – | 101 |
|
|
2016
Q2 | $1.69M | Buy |
+50,000
| New | +$1.69M | 0.07% | 90 |
|
|
2016
Q1 | – | Sell |
-371,000
| Closed | -$28.5M | – | 112 |
|
|
2015
Q4 | $28.5M | Sell |
371,000
-331,485
| -47% | -$25.5M | 1.15% | 33 |
|
|
2015
Q3 | $28.9M | Buy |
702,485
+490,485
| +231% | +$20.2M | 1.12% | 32 |
|
|
2015
Q2 | $15M | Buy |
+212,000
| New | +$15M | 0.5% | 61 |
|